Low-Dose Aspirin Linked to Lower Dementia Risk in Specific Genetic Profile

Researchers have found a potential clue to preventing dementia in older adults with a specific genetic profile. A study discovered that those with this profile who took low-dose aspirin had a 70% lower relative risk of dementia. This finding suggests that genetics may play a role in why some people benefit from low-dose aspirin while others do not. The study's results are based on previous research that found no overall protective effect of low-dose aspirin on dementia risk. The inexpensive medication could hold promise for preventing dementia in certain individuals. Further research is needed to confirm these findings and understand the relationship between genetics and aspirin's effects on dementia risk. The study's results may lead to new insights into the prevention of dementia and the development of targeted treatments.